EXACT Sciences Corporation (NASDAQ:EXAS) went higher by +8.50% to close at $ 12.25. The company exchanged total volume of 10.53 million shares throughout course of last trade however it holds an average trading capacity of 3.8 million shares. Shares of company began trading at $11.25 climbed to high of $13.20 touched the low of $11.25.
The company is trading above its 50-day moving averages of 7.80 and up from 200-day moving averages of 7.15. The firm has price to book ratio of 3.83 and its price to sale ratio was 22.08.
Exact Sciences Corporation’s (EXAS) has price-to-cash ratio of 4.56 and price to sale ratio of 23.96. The company gross profit margin is 41.30%. A look on the firm performance, its monthly performance is 83.38% and a quarterly performance of 76.01%. The stock price is moving up from its 20 days moving average with 32.47% and isolated positively from 50 days moving average with 63.12%.
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) dropped -2.07% and closed the trade at $ 6.62. The company recorded a trading capacity of 1.79 million shares above its three months average daily volume of 1.46 million shares. During the last trade, shares reached to high price of $6.88 and touched the low price of $6.51. The stock’s 50-day moving average is noted at $5.92 and its 200-day moving average is stands at $4.82.
Additionally, the company has EPS of -1.30. The company has market capitalization of $700.53M.
The average true range of Keryx Biopharmaceuticals Inc.’s (KERX) is recorded at 0.34 and the relative strength index of the stock stands 61.12. The stock price is going above to its 52 week low with 136.43% and lagging behind from its 52 week high with -37.01%. Analyst recommendation for this stock stands at 2.20. A look on the firm performance, its monthly performance is 10.70% and a quarterly performance of 43.91%. The stock price is trading upbeat from its 200 days moving average with 39.78% and up from 50 days moving average with 15.19%.